seedy19tron

5.0 ★★★★★ Posted today

Biotech trader, L/S

@seedy19tron · tracked since Mar 2026

Follow Twitter

Ideas 7

Long / short 7 L/0 S

Win rate 57%

Tracked posts 66 1.20/day

Avg return +11.9%

Long return +11.9%

Short return -

New ideas 2 last 30d

Most mentioned

Best trades

SLNO Long +58.4% OVID Long +21.1% XBI Long +9.6% COGT Long +4.7% BCRX Long -1.8%

Worst trades

NVS Long -5.4% BMY Long -3.3% BCRX Long -1.8% COGT Long +4.7% XBI Long +9.6%

Pick return distribution

Live distribution of all picks with entry price. Right tail = home runs.

< -30%-30/-10-10/00/+20+20/+50+50/+100> +100%

Bottom 10%

Median

Top 10%

Average returns

first-opened thesis horizon: return + win-rate

7 days 7 eval.

+0.5%

L +0.5% S -

Win rate 57%

30 days 8 eval.

+11.2%

L +11.2% S -

Win rate 62%

90 days 0 eval.

L - S -

Win rate -

Closed-window returns from the first opened position per ticker/side. 90d = picks opened 90+ days ago

Ticker

Side

Theme

Entry

P&L

Thesis

First opened

Mentions

Source

SLNO

Long

Healthcare

$33.39

+58.4%

The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.

Mar 15

TWITTER

COGT

Long

Healthcare

$35.09

+4.7%

Initiating a long position in COGT, with a deeper fundamental dive expected to follow.

Apr 07

TWITTER

BCRX

Long

Healthcare

$9.37

-1.8%

Buy BioCryst Pharmaceuticals as underlying prescription data remains solid and supports the fundamental picture despite ongoing market rumors.

Apr 16

TWITTER

BMY

Long

Healthcare

$59.33

-3.3%

BP is reportedly exploring potential M&A opportunities involving Novartis's oncology unit and Bristol Myers Squibb's neurology division.

Apr 03

TWITTER

NVS

Long

Healthcare

$152.84

-5.4%

BP is reportedly exploring potential M&A opportunities involving Novartis's oncology unit and Bristol Myers Squibb's neurology division.

Apr 03

TWITTER

XBI

Long

Healthcare

$121.94

+9.6%

The user anticipates outperformance for the XBI biotech ETF following double M&A activity.

Mar 31

TWITTER

OVID

Long

Healthcare

$2.42

+21.1%

The author expresses a positive outlook on OVID data and expects the stock price to exceed $3.

Mar 18

TWITTER

Showing 7 of 7 picks · sorted by mentions